Terms: = Thyroid cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717
41 results:
1. Sciellin promotes the development and progression of thyroid cancer through the jak2/STAT3 signaling pathway.
Guo H; Wang Z; Yin K; Ma R; Zhang Y; Yin F; Li H; Yin D
Mol Carcinog; 2024 Apr; 63(4):701-713. PubMed ID: 38411346
[TBL] [Abstract] [Full Text] [Related]
2. [Etiological analysis of a patient with multiple primary malignant neoplasms].
Shi PJ; Li YB; Xiao HP
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(47):3848-3851. PubMed ID: 38123227
[TBL] [Abstract] [Full Text] [Related]
3. PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer.
Chen Q; Hu Q; Chen Y; Shen N; Zhang N; Li A; Li L; Li J
Cell Death Dis; 2023 Oct; 14(10):655. PubMed ID: 37813837
[TBL] [Abstract] [Full Text] [Related]
4. The Experience of a Single Tertiary Center Regarding Benign and Malignant Tumors in Acromegalic Patients.
Plotuna IS; Balas M; Golu I; Amzar D; Vlad A; Moleriu LC; Vlad M
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374352
[No Abstract] [Full Text] [Related]
5. AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis.
Sun Z; Jiang Q; Gao B; Zhang X; Bu L; Wang L; Lin Y; Xie W; Li J; Guo J
Cancer Res; 2023 Apr; 83(8):1264-1279. PubMed ID: 36806887
[TBL] [Abstract] [Full Text] [Related]
6. BGN/FAP/STAT3 positive feedback loop mediated mutual interaction between tumor cells and mesothelial cells contributes to peritoneal metastasis of gastric cancer.
Wu H; Xiang Z; Huang G; He Q; Song J; Dou R; Yang C; Wang S; Xiong B
Int J Biol Sci; 2023; 19(2):465-483. PubMed ID: 36632455
[TBL] [Abstract] [Full Text] [Related]
7. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating jak2/STAT3 signaling.
Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
[TBL] [Abstract] [Full Text] [Related]
8. Nav1.6 promotes the progression of human follicular thyroid carcinoma cells via JAK-STAT signaling pathway.
Li H; Liu J; Fan N; Wang H; Thomas AM; Yan Q; Li S; Qin H
Pathol Res Pract; 2022 Aug; 236():153984. PubMed ID: 35753135
[TBL] [Abstract] [Full Text] [Related]
9. Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast cancer.
Schneider J; Jeon YW; Suh YJ; Lim ST
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269680
[TBL] [Abstract] [Full Text] [Related]
10. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract] [Full Text] [Related]
11. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
[TBL] [Abstract] [Full Text] [Related]
12. A Case of Thrombotic Vasculopathy in the Setting of High-Dose Hydroxyurea Use.
Michalak J; Simman R; Oostra D
Wounds; 2021 Dec; 33(12):E79-E84. PubMed ID: 34882096
[TBL] [Abstract] [Full Text] [Related]
13. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways.
Li C; Zhu L; Fu L; Han M; Li Y; Meng Z; Qiu X
Diagn Pathol; 2021 Oct; 16(1):93. PubMed ID: 34689819
[TBL] [Abstract] [Full Text] [Related]
14. Curcumin inhibits proliferation and invasion of papillary thyroid carcinoma cells by inhibiting the jak2 / STAT3 pathway.
Hu Y; Zhou N; Zhu Q
J BUON; 2021; 26(4):1635-1641. PubMed ID: 34565029
[TBL] [Abstract] [Full Text] [Related]
15. Stress-induced phosphoprotein 1 facilitates breast cancer cell progression and indicates poor prognosis for breast cancer patients.
Lin L; Wen J; Lin B; Xia E; Zheng C; Ye L; Wang Y; Wang O; Chen Y
Hum Cell; 2021 May; 34(3):901-917. PubMed ID: 33665786
[TBL] [Abstract] [Full Text] [Related]
16. Sclerosing Extramedullary Hematopoietic Tumor: A Case Report.
Wang D; Castro E; Rao A; McPhaul CM
J Investig Med High Impact Case Rep; 2020; 8():2324709620956463. PubMed ID: 32911987
[TBL] [Abstract] [Full Text] [Related]
17. PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced thyroid cancer.
Gray KD; McCloskey JE; Vedvyas Y; Kalloo OR; Eshaky SE; Yang Y; Shevlin E; Zaman M; Ullmann TM; Liang H; Stefanova D; Christos PJ; Scognamiglio T; Tassler AB; Zarnegar R; Fahey TJ; Jin MM; Min IM
Clin Cancer Res; 2020 Nov; 26(22):6003-6016. PubMed ID: 32887724
[TBL] [Abstract] [Full Text] [Related]
18. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
[TBL] [Abstract] [Full Text] [Related]
19. S-adenosylmethionine induces apoptosis and cycle arrest of gallbladder carcinoma cells by suppression of jak2/STAT3 pathways.
Liu Y; Bi T; Yuan F; Gao X; Jia G; Tian Z
Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2507-2515. PubMed ID: 32219484
[TBL] [Abstract] [Full Text] [Related]
20. Nevirapine inhibits migration and invasion in dedifferentiated thyroid cancer cells.
Shang H; Zhao J; Yao J; Wang H; Wang S; Dong J; Liao L
Thorac Cancer; 2019 Dec; 10(12):2243-2252. PubMed ID: 31631580
[TBL] [Abstract] [Full Text] [Related]
[Next]
